Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma of the Lungs”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00755170
What this trial is testing

Metronomic Vinorelbine and Bevacizumab in Patients With Non Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Hellenic Oncology Research Group 48
Testing effectiveness (Phase 2)Active Not RecruitingNCT04561362
What this trial is testing

Study BT8009-100 in Subjects With Nectin-4 Expressing Advanced Malignancies

Who this might be right for
Urinary Bladder NeoplasmTriple Negative Breast NeoplasmsHormone Receptor Positive, HER2-negative Neoplasms+5 more
BicycleTx Limited 329
Not applicableLooking for participantsNCT07070362
What this trial is testing

Digital Early Warning System for Acute Lung Injury in Liver Surgery

Who this might be right for
Acute Lung Injury(ALI)Liver CirrhosisARDS, Human+4 more
Beijing Tsinghua Chang Gung Hospital 3,000
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07247786
What this trial is testing

Study for Evaluating the Safety and Feasibility of Fecal Microbiota Transplant in Stage II-III NSCLC Patients Using ICI Responders as Donors (MIGRANT)

Who this might be right for
Non Small Cell Lung CancerRespiratory Tract Neoplasm
Fundación GECP 68
Large-scale testing (Phase 3)Looking for participantsNCT06031246
What this trial is testing

Selective Lymph Node Dissection for cT1N0M0 Invasive NSCLC With CTR>0.5 Located in the Apical Segment (ECTOP-1018)

Who this might be right for
Lung AdenocarcinomaLymph Node Metastasis
Fudan University 634
Testing effectiveness (Phase 2)WithdrawnNCT03266159
What this trial is testing

A Dose Escalation Study to Investigate the Safety, Pharmacokinetics (PK), Pharmacodynamics (PD), and Clinical Activity of GSK525762 Plus Trametinib in Subjects With Solid Tumors

Who this might be right for
Solid Tumours
GlaxoSmithKline
Testing effectiveness (Phase 2)Active Not RecruitingNCT03970746
What this trial is testing

Safety, Immunogenicity and Preliminary Clinical Activity Study of PDC*lung01 Cancer Vaccine in NSCLC

Who this might be right for
Non Small Cell Lung Cancer
PDC*line Pharma SAS 73
Early research (Phase 1)Study completedNCT02166242
What this trial is testing

Ethaselen for the Treatment of Thioredoxin Reductase High Expression Advanced Non-small Cell Lung Cancers

Who this might be right for
Carcinoma, Non-small Cell Lung
Hunan Province Tumor Hospital 40
Early research (Phase 1)Study completedNCT02197247
What this trial is testing

Study to Assess the Effect of Rifampicin on Blood Levels and Safety of AZD9291, in Patients With EGFRm+ NSCLC

Who this might be right for
Non Small Cell Lung Cancer
AstraZeneca 41
Testing effectiveness (Phase 2)Looking for participantsNCT06109558
What this trial is testing

The Efficacy and Safety of LMV-12 Combined With Osimertinib in NSCLC

Who this might be right for
Non Small Cell Lung CancerRET Gene MutationMET Amplification+1 more
Hunan Province Tumor Hospital 120
Not applicableUnknownNCT04984148
What this trial is testing

Construction of CT Radiomics Model for Predicting the Efficacy of Immunotherapy in Patients With Stage III NSCLC

Who this might be right for
Stage III Non-small Cell Lung Cancer
Guangdong Provincial People's Hospital 70
Large-scale testing (Phase 3)UnknownNCT03402048
What this trial is testing

The EPIC Trial The Elderly Patient Individualized Chemotherapy Trial

Who this might be right for
Stage IV, NSCLCLung NeoplasmsBronchial Neoplasms+6 more
University of Turin, Italy 567
Early research (Phase 1)Looking for participantsNCT06596915
What this trial is testing

Safety and Efficacy of BA1302 in Patients With Advanced Solid Tumors

Who this might be right for
Non-Small Cell Lung CancerPancreatic AdenocarcinomaBreast Cancer+1 more
Shandong Boan Biotechnology Co., Ltd 167
Early research (Phase 1)Study completedNCT04879849
What this trial is testing

TAK-676 With Pembrolizumab After Radiation Therapy to Treat a Number of Cancers

Who this might be right for
Carcinoma, Non-Small-Cell LungTriple Negative Breast NeoplasmsSquamous Cell Carcinoma of Head and Neck
Takeda 34
Testing effectiveness (Phase 2)Study completedNCT03573947
What this trial is testing

Phase II Clinical Trial of NIVO-IPI-TAXANE in Untreated Metastatic NSCLC

Who this might be right for
Non-small Cell Lung Cancer
Jeffrey Clarke 46
Not applicableUnknownNCT03896958
What this trial is testing

The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology)

Who this might be right for
Cancer, All TypesCancer of LiverCancer of Stomach+42 more
SpeciCare 1,000
Testing effectiveness (Phase 2)Ended earlyNCT02485652
What this trial is testing

Phase II Trial of HM61713 for the Treatment of ≥2nd Line T790M Mutation Positive Adenocarcinoma of the Lung

Who this might be right for
Non Small Cell Lung Cancer
Hanmi Pharmaceutical Company Limited 162
Testing effectiveness (Phase 2)Ended earlyNCT00532025
What this trial is testing

Sorafenib in Resected Non-small Cell Lung Carcinoma

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Johannes Gutenberg University Mainz 134
Testing effectiveness (Phase 2)Looking for participantsNCT07079475
What this trial is testing

Study of Oral EGFR Inhibitor DZD6008 Combined With Sunvozertinib in Patients Who Have Advanced NSCLC With EGFR Mutations (TIAN-SHAN8)

Who this might be right for
Non-Small Cell Lung Cancer
Dizal Pharmaceuticals 220
Not applicableStudy completedNCT00019201
What this trial is testing

Fluorescent Light Bronchoscopy Plus White Light Bronchoscopy for Early Detection of Lung Cancer

Who this might be right for
Head and Neck CancerLung Cancer
National Cancer Institute (NCI)
Next Page